Preferred Label : Lipodystrophy, congenital generalized, type 1;
Symbol : CGL1;
CISMeF acronym : BSCL1; CGL1;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Lipodystrophy, berardinelli-seip congenital, type 1; BSCL1; Brunzell syndrome, agpat2-related; Berardinelli-seip congenital lipodystrophy, type 1;
Description : Congenital generalized lipodystrophy (CGL), or Berardinelli-Seip syndrome, is a rare
autosomal recessive disease characterized by a near absence of adipose tissue from
birth or early infancy and severe insulin resistance. Other clinical and biologic
features include acanthosis nigricans, muscular hypertrophy, hepatomegaly, altered
glucose tolerance or diabetes mellitus, and hypertriglyceridemia (Garg, 2004). - Genetic
Heterogeneity of Congenital Generalized Lipodystrophy Congenital generalized lipodystrophy
type 2 (269700) is caused by mutation in the BSCL2 gene (606158). Congenital generalized
lipodystrophy type 3 (612526) is caused by mutation in the CAV1 gene (601047). Congenital
generalized lipodystrophy type 4 (613327) is caused by mutation in the PTRF gene (603198).;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutations in the 1-acylglycerol-3-phosphate O-acyltransferase 2 gene (AGPAT2,
603100.0001);
Laboratory abnormalities : Hyperinsulinemia; Hypertriglyceridemia; Decreased serum leptin; Elevated liver enzymes;
Prefixed ID : #608594;
Origin ID : 608594;
UMLS CUI : C1720862;
Automatic exact mappings (from CISMeF team)
Broader ORDO disease(s)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT